<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Sch of Biological and Chemical Sciences</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C2DF1B50-C0B3-4452-9247-287E94358B2E"><gtr:id>C2DF1B50-C0B3-4452-9247-287E94358B2E</gtr:id><gtr:firstName>Christopher D.</gtr:firstName><gtr:surname>Bray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FG041431%2F1"><gtr:id>FEED6310-56B5-47A1-A0C8-AA34604E1D8F</gtr:id><gtr:title>ortho-Quinone Methides in Natural Product Synthesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/G041431/1</gtr:grantReference><gtr:abstractText>Some years ago, the predominant view of benzynes, carbenes and radicals was that they were uncontrollably reactive and so could not be used in the construction of complex natural products. This perception has of course changed and such species are now routinely employed in synthesis. It can be argued that such a view is still held of ortho-quinone methides (o-QMs). These species have long been documented and much is known about how Nature utilises their high reactivity. For example, they are released as a means of defence by plants and insects whereas oxidation of vitamin E and dimerisation of the resultant ortho-quinone methides is used by the body as a storage mechanism. Also, the therapeutic benefit of a number of important chemotherapy drugs is based upon their ability to form an ortho-quinone methide in vivo. Despite this widespread use in biological systems, the application of ortho-quinone methides in total synthesis is extremely limited. The current program of research will look to develop the chemistry of ortho-quinone methides such that they can then be applied in the total synthesis of some biologically important molecules. The research will contribute to our fundamental knowledge of the chemistry of ortho-quinone methides and will promote the benefits of these highly useful species in all branches of synthetic chemistry.</gtr:abstractText><gtr:fund><gtr:end>2013-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>232826</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>49000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Queen Mary Innovation</gtr:department><gtr:description>Proof of Concept Innovation Fund</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Queen Mary University of London</gtr:fundingOrg><gtr:id>50B591F4-8FDB-422F-94E8-3C07272434B5</gtr:id><gtr:outcomeId>5464aec82e1ac5.75961086</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The original target was the total synthesis of two structurally similar natural products, both of which possessed significant biological activity. The first compound was synthesised by groups in the USA and Germany prior to the researchers on this grant commencing. We examined alternative routes to those that had already been published but ultimately we could not better their approach. The second natural product we have partially synthesised. We have validated our original hypothesis for the approach to this compound and we have made a number of analogues. This methodology will be useful to a number of groups and may yet prove the best strategy to take with these compounds.</gtr:description><gtr:exploitationPathways>Spirocycles are an emerging area of interest in medicinal chemistry and the methodology we have developed will be useful in accessing such structures in a highly succinct and efficient manner.</gtr:exploitationPathways><gtr:id>E0AB872A-92DA-4D84-A6D8-97EC3C32A9C6</gtr:id><gtr:outcomeId>5464b8a7993ce4.78159840</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://brayresearch.org</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2BC13730-92A3-4659-B7D7-B1AACFAF5F96</gtr:id><gtr:title>An operationally simple, palladium catalysed dehydrogenative cross-coupling reaction of pyridine N-oxides and thiazoles &amp;quot;on water&amp;quot;</gtr:title><gtr:parentPublicationTitle>RSC Advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1107395c297a978cab9da1ce8dffded4"><gtr:id>1107395c297a978cab9da1ce8dffded4</gtr:id><gtr:otherNames>Willis N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>doi_55f95d95d5c03fd3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9C5362A-B4B7-4425-9305-473994847D7B</gtr:id><gtr:title>ortho-Quinone methides in natural product synthesis.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/633d5eb6c1b5887993f567335955882e"><gtr:id>633d5eb6c1b5887993f567335955882e</gtr:id><gtr:otherNames>Willis NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>5464aa09a544a2.30993117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C6B03A0-C529-4540-AFDA-C4055FF6396B</gtr:id><gtr:title>Single-molecule in vivo imaging of bacterial respiratory complexes indicates delocalized oxidative phosphorylation.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d834fc1ed7599e954a8dcf7d0dc59d0d"><gtr:id>d834fc1ed7599e954a8dcf7d0dc59d0d</gtr:id><gtr:otherNames>Llorente-Garcia I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>5464aa09826fc7.57237723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66162705-8C50-4BD0-BB94-0FDBAF6719DE</gtr:id><gtr:title>Stereocontrolled synthesis of quaternary cyclopropyl esters.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fa744dcba60a8ef662528758bc40530"><gtr:id>3fa744dcba60a8ef662528758bc40530</gtr:id><gtr:otherNames>Bray CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5464aa09cbd352.11740894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F4CA01C-7A39-401A-AF74-1C9B32FD51F7</gtr:id><gtr:title>Direct conversion of epoxides into aziridines with N-arylphosphoramidates</gtr:title><gtr:parentPublicationTitle>Tetrahedron Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dc9c66fcb81802d2e3291fe08bde721"><gtr:id>0dc9c66fcb81802d2e3291fe08bde721</gtr:id><gtr:otherNames>Minicone F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5464aa09f0a0d1.94345961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91EF3A6F-8CBA-4457-969E-3667896B9B01</gtr:id><gtr:title>An ortho-quinone methide based strategy towards the rubromycin spiroketal family</gtr:title><gtr:parentPublicationTitle>RSC Advances</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1107395c297a978cab9da1ce8dffded4"><gtr:id>1107395c297a978cab9da1ce8dffded4</gtr:id><gtr:otherNames>Willis N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>5675ee82b4a6c</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G041431/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>0B9701E7-D17F-4963-82DA-B3926A65B50A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Biological &amp; Medicinal Chem.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>454398F2-57A6-4959-8845-0F248CF4D5C4</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical Synthetic Methodology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>